Ashland Reports Fiscal Q1 2026 Results and Outlook
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Ashland ( (ASH) ) just unveiled an announcement.
On February 2, 2026, Ashland reported first‑quarter fiscal 2026 results for the period ended December 31, 2025, showing sales of $386 million, down 5% year over year, with the previously announced Avoca divestiture accounting for about two percentage points of the decline and contributing to a 5% drop in adjusted EBITDA to $58 million. The company posted a net loss of $12 million and a loss from continuing operations of $14 million, but improved adjusted operating income to $14 million and generated $125 million in operating cash flow aided by a $103 million tax refund, while Life Sciences delivered growth on resilient pharma demand, Personal Care held up despite softness in hair care and the Avoca sale, Specialty Additives and Intermediates faced weaker demand and competitive pressure, and management narrowed full‑year fiscal 2026 adjusted EBITDA guidance to $400–$420 million to reflect temporary margin headwinds from a Calvert City equipment outage and weather‑related disruptions, underscoring both operational resilience and near‑term challenges for investors and other stakeholders.
The most recent analyst rating on (ASH) stock is a Buy with a $70.00 price target. To see the full list of analyst forecasts on Ashland stock, see the ASH Stock Forecast page.
Spark’s Take on ASH Stock
According to Spark, TipRanks’ AI Analyst, ASH is a Neutral.
The score is held back mainly by weak profitability and declining revenue despite improving free cash flow and manageable leverage. Technicals are a meaningful positive with price above key moving averages and healthy momentum. Valuation is mixed due to a supportive dividend but a negative P/E tied to losses, while earnings-call guidance suggests incremental improvement but with notable demand and execution headwinds.
To see Spark’s full report on ASH stock, click here.
More about Ashland
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with leadership positions in high‑quality, consumer‑focused markets, including pharmaceuticals, personal care and architectural coatings, supplying specialty formulations and functional ingredients to customers across these sectors.
Average Trading Volume: 828,545
Technical Sentiment Signal: Sell
Current Market Cap: $2.8B
See more data about ASH stock on TipRanks’ Stock Analysis page.
